Organogenesis Holdings Inc (ORGO)
NASDAQ
The current ORGO market cap is 387.78M. The company's latest EPS is USD 0.0373 and P/E is 78.28.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 117.32M | 108.53M | 99.65M | 109.98M | 130.23M |
Operating Income | 9.75M | 8.05M | -3.15M | -3.85M | -13.89M |
Net Income | 5.32M | 3.17M | -568k | -2.1M | -17.04M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 260.98M | 338.3M | 468.06M | 450.89M | 433.14M |
Operating Income | -29.46M | 27.42M | 72.92M | 22.3M | 12.53M |
Net Income | -40.45M | 17.95M | 94.9M | 15.53M | 4.95M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 450.31M | 462.65M | 460.03M | 458.48M | 443.16M |
Total Liabilities | 179.03M | 185.78M | 181.36M | 180.45M | 179.66M |
Total Equity | 271.28M | 276.87M | 278.66M | 278.03M | 263.5M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 220.69M | 294.49M | 443.26M | 449.36M | 460.03M |
Total Liabilities | 165.1M | 148.41M | 201.22M | 183.69M | 181.36M |
Total Equity | 55.58M | 146.08M | 242.04M | 265.67M | 278.66M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 3.57M | 20.3M | 30.92M | -10.16M | -5.42M |
Investing | -15.06M | -21.04M | -24.36M | -2.22M | -4.1M |
Financing | -2.29M | -3.73M | -5.51M | -2.61M | -4.34M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -33.53M | 6.8M | 61.98M | 24.86M | 30.92M |
Investing | -6.23M | -24.83M | -31.22M | -33.9M | -24.36M |
Financing | 78.73M | 42.47M | -1.04M | -2.2M | -5.51M |
Market Cap | 387.78M |
Price to Earnings Ratio | 78.28 |
Price to Sales Ratio | 0.89 |
Price to Cash Ratio | 3.73 |
Price to Book Ratio | 1.39 |
Dividend Yield | - |
Shares Outstanding | 132.58M |
Average Volume (1 week) | 496.77k |
Average Volume (1 Month) | 498.33k |
52 Week Change | 25.00% |
52 Week High | 4.705 |
52 Week Low | 1.96 |
Spread (Intraday) | 0.01 (0.34%) |
Company Name | Organogenesis Holdings Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://organogenesis.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.